nitrofurantoin has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broe, A; Hargreave, M; Hemmingsen, CH; Hjorth, S; Leinonen, MK; Nörby, U; Nordeng, H; Pottegård, A | 1 |
| Aguiar, JS; Andrade, JK; Barros, AL; Brondani, DJ; Gomes Filho, MA; Militão, GC; Nascimento, SC; Rodrigues, MD; Silva, DM; Silva, PB; Silva, TG; Souza, MI | 1 |
2 other study(ies) available for nitrofurantoin and Leukemia
| Article | Year |
|---|---|
Prenatal exposure to nitrofurantoin and risk of childhood leukaemia: a registry-based cohort study in four Nordic countries.
Topics: Amdinocillin Pivoxil; Child; Cohort Studies; Female; Humans; Infant; Leukemia; Nitrofurantoin; Pregnancy; Prenatal Exposure Delayed Effects; Registries; Risk Factors; Scandinavian and Nordic Countries | 2022 |
N-pentyl-nitrofurantoin induces apoptosis in HL-60 leukemia cell line by upregulating BAX and downregulating BCL-xL gene expression.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; DNA Fragmentation; Down-Regulation; Gene Expression; HL-60 Cells; Humans; Leukemia; Mitochondria; Nitrofurantoin; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2016 |